IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular inflammation and proteinuria.
Zacks.com on MSN17h
APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority TagThe FDA accepts Apellis' sNDA seeking label expansion of Empaveli to treat two rare kidney diseases for review under the Priority Review pathway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback